Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,005 | 121 | 99.9% |
| Education | $5.79 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $445.53 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.43 | 15 | $0 (2023) |
| Abbott Laboratories | $300.26 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $231.39 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $194.68 | 3 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $188.48 | 9 | $0 (2019) |
| Medtronic USA, Inc. | $183.06 | 4 | $0 (2018) |
| Kestra Medical Technology Services, Inc. | $177.70 | 1 | $0 (2023) |
| Cardiovascular Systems Inc. | $168.77 | 4 | $0 (2017) |
| Allergan, Inc. | $159.45 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.20 | 1 | PFIZER INC. ($21.20) |
| 2023 | $447.22 | 7 | Kestra Medical Technology Services, Inc. ($177.70) |
| 2022 | $212.43 | 2 | Abbott Laboratories ($147.42) |
| 2021 | $373.27 | 5 | Veryan Medical Incorporated ($145.50) |
| 2020 | $65.03 | 4 | Allergan, Inc. ($32.61) |
| 2019 | $399.38 | 20 | E.R. Squibb & Sons, L.L.C. ($85.79) |
| 2018 | $854.17 | 34 | Medtronic USA, Inc. ($183.06) |
| 2017 | $1,638 | 50 | PFIZER INC. ($256.31) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $177.70 | General |
| Category: Cardiology | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $101.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $96.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Obesity | ||||||
| 01/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 10/29/2022 | Teleflex LLC | MANTA (Device) | Food and Beverage | In-kind items and services | $65.01 | General |
| Category: Interventional Access | ||||||
| 02/28/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $147.42 | General |
| Category: Neuromodulation | ||||||
| 12/29/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $53.34 | General |
| Category: Neuromodulation | ||||||
| 10/04/2021 | BOSTON SCIENTIFIC CORPORATION | LUX-DX (Device) | Food and Beverage | Cash or cash equivalent | $23.82 | General |
| Category: LUXDx | ||||||
| 05/18/2021 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $36.51 | General |
| Category: Devices | ||||||
| 03/02/2021 | Veryan Medical Incorporated | BioMimics (Device) | Food and Beverage | Cash or cash equivalent | $145.50 | General |
| Category: vascular stent | ||||||
| 01/28/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug), NEXLIZET | Food and Beverage | In-kind items and services | $114.10 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/24/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/05/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/26/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/20/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $85.79 | General |
| Category: Cardiovascular | ||||||
| 11/19/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 890 | 1,204 | $406,261 | $110,349 |
| 2022 | 14 | 931 | 1,270 | $419,390 | $110,460 |
| 2021 | 17 | 747 | 1,070 | $381,288 | $105,156 |
| 2020 | 14 | 736 | 997 | $357,522 | $95,323 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 146 | 175 | $86,100 | $23,663 | 27.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 185 | $57,165 | $16,856 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 172 | $54,008 | $13,361 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $36,273 | $13,177 | 36.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 53 | 121 | $32,307 | $8,707 | 27.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 115 | 139 | $32,943 | $7,908 | 24.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 59 | $35,518 | $7,326 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 46 | $19,550 | $5,736 | 29.3% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 13 | 50 | $18,250 | $4,281 | 23.5% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 12 | 29 | $15,370 | $3,990 | 26.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 35 | 37 | $11,729 | $3,246 | 27.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 68 | 68 | $3,672 | $1,185 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $3,376 | $911.23 | 27.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 158 | 180 | $88,560 | $22,410 | 25.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 217 | $67,053 | $16,871 | 25.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 98 | 98 | $33,222 | $12,384 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 144 | $45,216 | $11,188 | 24.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 130 | 154 | $36,498 | $9,198 | 25.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 54 | 140 | $37,380 | $8,921 | 23.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 51 | $30,702 | $7,500 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 41 | $17,425 | $5,477 | 31.4% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 13 | 53 | $21,359 | $5,417 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 43 | 44 | $13,948 | $3,370 | 24.2% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 11 | 23 | $13,363 | $3,262 | 24.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 95 | 95 | $5,130 | $1,673 | 32.6% |
About Dr. Nithin Bhandarkar, D.O
Dr. Nithin Bhandarkar, D.O is a Internal Medicine healthcare provider based in Canonsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1992943419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nithin Bhandarkar, D.O has received a total of $4,011 in payments from pharmaceutical and medical device companies, with $21.20 received in 2024. These payments were reported across 123 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,005).
As a Medicare-enrolled provider, Bhandarkar has provided services to 3,304 Medicare beneficiaries, totaling 4,541 services with total Medicare billing of $421,287. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Canonsburg, PA
- Active Since 01/22/2009
- Last Updated 03/15/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992943419
Products in Payments
- ELIQUIS (Drug) $317.63
- PRALUENT (Drug) $231.39
- FARXIGA (Drug) $222.14
- ENTRESTO (Drug) $194.68
- VRAYLAR (Drug) $182.68
- Assure WCD (Device) $177.70
- CHANTIX (Drug) $156.65
- PROCLAIM (Device) $147.42
- BioMimics (Device) $145.50
- VECTRIS (Device) $134.15
- XARELTO (Drug) $132.08
- Mobi-C (Device) $120.48
- NEXLETOL (Drug) $114.10
- LifeVest (Device) $96.59
- PRADAXA (Drug) $89.94
- XIFAXAN (Drug) $88.51
- Repatha (Biological) $87.50
- iFuse Implant (Device) $79.01
- SYMBICORT (Drug) $75.70
- MYRBETRIQ (Drug) $72.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Canonsburg
Yadavendra Rajawat, Md, MD
Internal Medicine — Payments: $13,457
Thomas Corkery, Do, DO
Internal Medicine — Payments: $1,094
Taranjit Gill
Internal Medicine — Payments: $519.08
Dr. Ashok Kumar, M.d, M.D
Internal Medicine — Payments: $498.75
Sukaina Jaffer, Md, MD
Internal Medicine — Payments: $204.21
Lauren Gugliotti
Internal Medicine — Payments: $140.03